{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:51:00Z","timestamp":1781769060055,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12032-019-1245-5","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T22:02:27Z","timestamp":1546984947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3703-1268","authenticated-orcid":false,"given":"Grzegorz","family":"Helbig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Wieczorkiewicz-Kabut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miros\u0142aw","family":"Markiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Krzemie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"W\u00f3jciak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Bia\u0142as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Kopera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Rzenno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Wo\u017aniczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kopi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Grygoruk-Wi\u015bniowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kocl\u0119ga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"issue":"12","key":"1245_CR1","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/ajh.24592","volume":"91","author":"A Tefferi","year":"2016","unstructured":"Tefferi A. Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016;91(12):1262\u201371.","journal-title":"Am J Hematol"},{"key":"1245_CR2","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1038\/bcj.2011.36","volume":"1","author":"F Cervantes","year":"2011","unstructured":"Cervantes F. How I treat splenomegaly in myelofibrosis. Blood Cancer J. 2011;1:e37. \n                    https:\/\/doi.org\/10.1038\/bcj.2011.36\n                    \n                  .","journal-title":"Blood Cancer J"},{"issue":"26","key":"1245_CR3","doi-asserted-by":"publisher","first-page":"5264","DOI":"10.1182\/blood-2009-07-234880","volume":"114","author":"N Kroger","year":"2009","unstructured":"Kroger N, Holler E, Kobbe G, et al. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis. A prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Blood. 2009;114(26):5264\u201370.","journal-title":"Blood"},{"issue":"3","key":"1245_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.bbmt.2009.10.025","volume":"16","author":"KK Ballen","year":"2010","unstructured":"Ballen KK, Shrestha S, Sobocinski KA, et al. Outcome of transplantation for myelofibrosis. Biol Bone Marrow Transplant. 2010;16(3):358\u201367.","journal-title":"Biol Bone Marrow Transplant"},{"issue":"3","key":"1245_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2141.2010.08417.x","volume":"152","author":"M Robin","year":"2011","unstructured":"Robin M, Tabrizi R, Mohty M, et al. Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC). Br J Haematol. 2011;152(3):331\u20139.","journal-title":"Br J Haematol"},{"issue":"6","key":"1245_CR6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbmt.2017.03.002","volume":"23","author":"M Robin","year":"2017","unstructured":"Robin M, Zine M, Chevret S, et al. The impact of splenectomy in myelofibrosis patients prior to allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23(6):958\u201364.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"1245_CR7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00277-016-2638-6","volume":"95","author":"A Gratwohl","year":"2016","unstructured":"Gratwohl A, Iacobelli S, Bootsman N, et al. Splenic irradiation before hematopietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study. Ann Hematol. 2016;95(6):967\u201372.","journal-title":"Ann Hematol"},{"issue":"12","key":"1245_CR8","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1080\/10428194.2017.1321747","volume":"58","author":"NS Kalman","year":"2017","unstructured":"Kalman NS, Mukhopadhyay ND, Roberts CH, et al. Low-dose splenic irradiation prior to hematopoietic cell transplantation in hypersplenic patients with myelofibrosis. Leuk Lymphoma. 2017;58(12):2983\u20134.","journal-title":"Leuk Lymphoma"},{"key":"1245_CR9","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1182\/blood-2014-10-605055","volume":"124","author":"OH Vyas","year":"2014","unstructured":"Vyas OH, Kaul E, Rosenberg AS, et al. Splenic irradiation and a reduced-intensity conditioning regimen prior to allogeneic stem cell transplantation for myelofibrosis. Blood. 2014;124:3170.","journal-title":"Blood"},{"key":"1245_CR10","first-page":"44","volume-title":"World health organization classification of tumours of hematopoietic and lymphoid tissues","author":"J Thiele","year":"2008","unstructured":"Thiele J, Kvasnicka HM, Tefferi A, et al. Primary myelofibrosis. In: Swierdlow SH, Campo N, Harris NL et al, editors. World health organization classification of tumours of hematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp.\u00a044\u20137."},{"issue":"9","key":"1245_CR11","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","volume":"115","author":"F Passamonti","year":"2010","unstructured":"Passamonti F, Cervantes F, Vannucchi AM, et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (international working group for myeloproliferative neoplasms research and treatment). Blood. 2010;115(9):1703\u20138.","journal-title":"Blood"},{"key":"1245_CR12","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1182\/blood.V97.7.2180","volume":"97","author":"Z Li","year":"2001","unstructured":"Li Z, Gooley T, Appelbaum FR, Deeg HJ. Splenectomy and hematopoietic stem cell transplantation for myelofibrosis. Blood. 2001;97:2180\u20131.","journal-title":"Blood"},{"key":"1245_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1365-2141.1998.00998.x","volume":"103","author":"MA Elliot","year":"1998","unstructured":"Elliot MA, Chen MG, Silverstein MN, Tefferi A. Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia. Br J Haematol. 1998;103:505\u201311.","journal-title":"Br J Haematol"},{"issue":"9","key":"1245_CR14","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ajh.21799","volume":"85","author":"A Pardanani","year":"2010","unstructured":"Pardanani A, Brown P, Neben-Wittich M, Tobin R, Tefferi A. Effective management of accelerated phase myelofibrosis with low-dose splenic radiotherapy. Am J Hematol. 2010;85(9):715\u20136.","journal-title":"Am J Hematol"},{"key":"1245_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/bmt.2012.249","volume":"48","author":"G Akpek","year":"2013","unstructured":"Akpek G, Pasquini MC, Logan B, et al. Effects of spleen status on early outcomes after hematopoietic cell transplantation. Bone Marrow Transplant. 2013;48:825\u201331.","journal-title":"Bone Marrow Transplant"},{"key":"1245_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8751329","author":"E Matsubara","year":"2016","unstructured":"Matsubara E, Yamanouchi J, Kitazawa R, et al. Usefulness of low-dose splenic irradiation prior to reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in elderly patients with myelofibrosis. Case Rep Hematol. 2016. \n                    https:\/\/doi.org\/10.1155\/2016\/8751329\n                    \n                  .","journal-title":"Case Rep Hematol"},{"key":"1245_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1620\/tjem.228.295","volume":"228","author":"T Ito","year":"2012","unstructured":"Ito T, Akagi K, Kondo T, Kawabata H, Ichinohe T, Takaori-Kondo A. splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly. Tohoku J Exp Med. 2012;228:295\u20139.","journal-title":"Tohoku J Exp Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-019-1245-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1245-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1245-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T19:18:26Z","timestamp":1578424706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-019-1245-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1245"],"URL":"https:\/\/doi.org\/10.1007\/s12032-019-1245-5","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"16"}}